Methods of treatment and pharmaceutical compositions using an sglt-2 inhibitor and a neuroleptic agent
US-2016074415-A1 · Mar 17, 2016 · US
US10442795B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10442795-B2 |
| Application number | US-201514805838-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 22, 2015 |
| Priority date | May 10, 2005 |
| Publication date | Oct 15, 2019 |
| Grant date | Oct 15, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to processes for preparing the compounds of general formula I, wherein the groups R 1 and R 3 are defined according to claim 1 . Furthermore this inventions relates to intermediates obtained in these processes.
Opening claim text (preview).
The invention claimed is: 1. Process for preparing the compounds of general formula II, wherein R 1 denotes R-tetrahydrofuran-3-yl or S-tetrahydrofuran-3-yl; and R 2 independently of one another denote hydrogen, (C 1-18 -alkyl)carbonyl, (C 1-18 -alkyl)oxycarbonyl, arylcarbonyl, aryl-(C 1-3 -alkyl)-carbonyl, aryl- C 1-3 -alkyl -alkyl, allyl, R a R b R c Si, or CR a R b OR c , wherein two adjacent groups R 2 may be linked with each other to form a bridging group SiR a R b , CR a R b or CR a OR b —CR a OR b ; R a , R b , R c independently of one another denote C 1-4 -alkyl, aryl or aryl-C 1-3 -alkyl, while the alkyl groups may be mono- or polysubstituted by halogen; L1 independently of one another are selected from among fluorine, chlorine, bromine, C 1-3 -alkyl , C 1-4 -alkoxy and nitro; while by the aryl groups mentioned in the definition of the above groups are meant phenyl or naphthyl groups, which may be mono-or polysubstituted with L1; said method comprised of the steps of reacting a glucose derivative of the formula XXXV wherein R 2 is defined as hereinbefore and Hal denotes F, Cl, Br, C 1-3 -alkylcarbonyloxy, C 1-3 -alkyloxycarbonyloxy or C 1-3 -alkyloxy; with a metallated aglycon of the formula VI wherein R 1 is defined as hereinbefore and M denotes a zinc moiety; to yield the product of the formula II. 2. The process according to claim 1 , wherein R 2 independently of one another denote C 1-4 -alkylcarbonyl, C 1-4 -alkyloxycarbonyl, arylmethyl or R a R b R c Si.
linked by a carbon chain containing aromatic rings · CPC title
Oxygen atoms · CPC title
Lithium compounds · CPC title
Oxygen atoms · CPC title
Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.